Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer

NCT00975429 is registered in ClinicalTrials.gov with Steba Biotech S.A. as lead sponsor.

NCT NCT00975429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00975429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascular-Targeted Photodynamic Therapy Using WST11 in Patients With Localized Prostate Cancer
Lead sponsor
Steba Biotech S.A.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
August 31, 2012
Enrollment
86 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer